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 Numerical aberrations of chromosomes 8, 11, 12, 17, X, 
and Y were investigated on fifteen cases of esophageal 
squamous cell carcinoma using fluorescence in situ hybridi-
zation (: FISH) with chromosome specific DNA probes. 
There were various aberrations in autosomal chromosomes. 
Trisomy 12 and trisomy 17 were the most common numerical 
aberrations (found in six cases, respectively), followed by 
trisomy 11 and monosomy 17 (in five cases, respectively), 
trisomy 8 (in four cases), tetrasomy 8 and monosomy 11 (in 
three cases, respectively). In regard to sex chromosomes, all 
cases except for one showed extra copy number of X chromo-
some, two signals were found in male and three signals were 
encountered in female. Loss of Y was found in six cases and 
gain of Y was shown in two cases. Quantification of nuclear 
DNA content by flow cytometry was performed using the 
same materials. Three of fifteen (20 %) revealed DNA 
diploidy on DNA histogram, but several numerical aberra-
tions were found in all DNA diploid cases by FISH. 
Comparing the results with clinicopathologic parameters, 
there is a good correlation between the number of chromo-
some 8 and lymph node metastasis (p = 0.0089). Numerical 
chromosome aberrations of esophageal cancer can be de-
tected easily in preoperative status using endoscopic biopsy 
specimens. FISH analysis correlates with the extent of 
disease and may be helpful to determine methods of surgical 
procedure for the patients with esophageal squamous cell 
carcinoma.
INTRODUCTION 
 The prognosis of patients with esophageal carcinoma is 
poor even if surgical resection is followed by chemotherapy 
and radiation therapy'). To permit more effective treat-
ment and to determine the etiology, more study concerning 
the biological characteristics of this aggressive cancer is 
necessary. In the current study, loss of heterozygosity was 
observed for regions of 17 p2> and for the p 533), RB1 (: 
retinoblastoma) 4), APC (: adenomatous polyposis coli) 5), 
and MCC (: mutated in colon cancer)') genetic loci in 
esophageal cancer. Chromosomal aberrations may reflect 
oncogenic changes and may relate to tumor progression
and aggressiveness. However, very few cytogenetic studies 
on esophageal cancer have been reported because of diffi-
culties in obtaining good metaphase spreads')-g). Recently, 
technological advances in the field of molecular 
cytogenetics have made it possible to detect chromosomal 
aberrations in interphase cells by using specific DNA 
probes for different centromeric resions together with 
fluorescence in situ hybridization (: FISH)")"). In this 
study, numerical aberrations of chromosomes 8, 11, 12, 17, 
X, and Y were analyzed on fifteen cases of esophageal 
cancers by FISH using chromosome specific repetitive DNA 
probes. As a result, a close correlation was shown between 
numerical chromosome aberrations and clinicopathologic 
features in esophageal cancer. In addition, this paper 
showed that preoperative determination of numerical 
chromosome aberrations was feasible by using endoscopic 
biopsy specimens for carcinomas of the esophagus.
MATERIALS AND METHODS 
Materials: 
 Pathological specimens for this study were obtained 
from patients who underwent surgical resection at the 
First Department of Surgery in Nagasaki University 
School of Medicine from 1989 to 1990. None of the patients 
had received neither chemotherapy nor radiation therapy 
until surgical resection was performed. All patients 
underwent a subtotal esophagectomy with regional lymph 
node dissection. Relationship between numerial chromo-
some aberrations and clinicopathologic parameters (pa-
tient's age, sex, tumor site, grade, depth of microscopic 
invasion, lymph node status, histologic stage, and tumor 
size) was analyzed. 
Sample preparation and flow cytometric analysis: 
 50,u m sections from formalin-fixed paraffin-embedded 
tissue were deparaffinized with xylene for 60 min. They 
were rehydrated through an ethanol series and then incu-
bated overnight with citrate buffer trypsin. After
centrifugation the pellets were resuspended in 0.3 ml DW 3 
and a half of nuclei were refixed by addition of 0.7 ml cold 
ethanol on vortex (final concentration: 70 %). These 
nuclei were stored at - 20°C before FISH. The remainder 
was centrifuged and nuclear DNA was stained by 
Vindel q5v's method. The fluorescence of the propidium 
iodide stained nuclei was analyzed in a FACS can (Becton 
Dickinson) and displayed as histograms of DNA content 
per nucleus versus number of nuclei. 
DNA probes: 
 Cloned centromeric alpha satellite DNAs from chromo-
some 8 (DM), 11 (pLC11A), 12 (pSP12-1), 17 (p17H8), X 
(pBamX7), and Y (DYZ1) were used in this study. These 
probes were labeled with biotin-11-dUTP by standard nick 
translation method. 
Fluorescence in situ hybridization 
 The cells were dropped on poly-L-lysin coated slides and 
air-dried. The slides were incubated with 0.1 % pepsin 
(Sigma Co)/0.1N HC1 for 10 minutes at 37°C to improve 
target accessibility. After washing with PBS ( - ), the 
slides were immersed in 70% acetic acid for 30 seconds at 
room temperature to remove residual cytoplasm. After 
washing and dehydration, the slides were immersed for 10 
minutes in 0.25 % acetic anhydrate/Tris HCl to block any 
residual aldehyde groups. After washing twice in 2 X SSC 
(: 0.3 M NaCl, 30 mM sodium citrate, pH 7.0), the slides 
were denatured for 2 minutes at 70 °C f ormamide, 2 X SSC. 
Formamide was deionized by treatment with a mixed -bed 
ion -exchange resin. The slides were dehydrated and air-
dried bef ore applying the probe. The probe was denatured 
for 10 minutes at 70'C in the hybridization mixture 
(containing 0.5 ,u g/ml DNA probe, 10 % dextran sulphate, 
2 X SSC and 500 ,u g/ml herring sperm DNA in 50 % f orm-
amide). The hybridization mixture (20# 1) was put under 
a 24 X 24 mm glass coverslip and placed in a humidified 
chamber. 
 After overnight hybrization at 37C the slides were 
washed twice for 10 minutes in 2 X SSC and subsequently 
once for 10 minutes in 60 % f ormamide, 2 X SSC at 45C. 
The slides were incubated with 5 g g/ml FITC conjugated 
avidin DCS (Vector Labo. Inc.) in BST buffer (: 2 % BSA, 
4XSSC, and 0.1 % Tween 20) for 30 minutes at 37°C and 
washed in 4SSCT (: 4 X SSC, 0.1 % Tween 20). If necessary, 
the probe-linked fluorescence was amplified by additional 
treatment with 5 ,u g/ml biotin-labeled goat-anti-avidin 
antibody (Vector Labo, Inc,) in BST buffer and 5 ,u g/ml 
FITC avidin DCS. After washing in 4SSCT, the nuclei were 
counterstained with 1,u g/ml propidium iodide (Sigma Co) 
in an antifade solution containing p-phenylendiamine 
dihydrochroride. 
FISH using endoscopic biopsy specimens: 
  Using flow cytometric quantification, nuclear DNA
contents from endoscopic biopsy specimen were in accor-
dance with those from paraffin-embedded tissue"". To 
ascertain whether endoscopic biopsy specimens are suitable 
to FISH for preoperative detection of numerical chrorno-
some aberrations, FISH was also applied to tumor 
implints from biopsy specimens (case 3 and case 12). The 
same manner was performed for FISH, but pretreatment 
was modified. Briefly, the slides were incubated with 0.01 
% pepsin/0.2N HC1 instead of 0.1 % pepsin/0.1 N HC1 and 
70 % acetic acid. 
Evaluation: 
 Hybridization results were analysed using fluoresecence 
microscopy (BH-2; Olympus). The number of hybridiza-
tion signals were counted in 100-200 interphase nuclei from 
each slides. Results were interpreted as significant for 
polysomy when greater than 15 % of the nuclei had more 
signals than diploid for a specific chromosome probe, 
while determination of hypodiploidy was based on finding 
that more than 20 % of the cells had fewer signals than 
expected for a diploid cell. 
 Fisher's exact probability test was used for statistical 
analysis between the numerical chromosome aberrations 
and clinicopathologic parameters. Differences causing P 




 Clinicopathologic data of the fifteen patients are 
summarized in Table 114). All tumors were squamous cell 
carcinomas. The mean patients age was 64.2 yesrs (range, 
43-78 years), there were two women and thirteen men. 
Lymph node metastasis was found in eight patients (53.3 
%). There were no cases with distant metastasis. 
Interphase cytogenetics: 
 Numerical chromosome aberrations were easily detect-
able using biopsy specimens. Detail of nuclear DNA 
contents and numerical chromosome aberrations were 
shown in Table 2. Numerical aberrations of chromosome 8 
were found in nine cases, monosomy in two, trisomy in 
four, and tetrasomy in three cases. In six of seven cases (86 
%) with gain of chromosome 8 had no lymph node metas-
tasis. By contrast, in seven of eight cases (88 %) without 
gain of chromosome 8 had several positive lymph node 
involvement. There was a good correlation between copy 
number of chromosome 8 had lymph node status in pa-
tients with esophageal cancer (p = 0.0089). Of six cases 
which did not invade to adventitia (mp), all three cases 
with gain of chromosome 8 had no lymph node involve-
ment and all three cases without gain had several lymph 
node metastases. The copy number of chromosome 8 did
Table 1. Clinicopathologoc features of 15 cases of 
         esophageal squamous cell carcinomas.
Characteristic No.(%) of patients 
All patients 15 
Sex 
 Male 13(87%) 
 Female 2 (13%) 
Age 
 <65 yr 7 (47%) 
 X65 yr 8 (53%) 
Tumor location 
 Ce/lu 5 (33%) 
 Im 7 (47%) 
 Ei 3 (20%) 
Grade 
 well 1 ( 7%) 
 moderate 10 (67%) 
 poor 4 (27%) 
Depth of invasion 
 mp 6 (40%) 
   a, 9 (60%) 
Lymph node status 
 negative 7 (47%) 
 positive 8(53%) 
Histological stage 
 stage I /11 7 (47%) 
 stage III/ IV 8 (53%)
Fig. 1 Flow cytometric DNA histogram of case 1 reveals 
      DNA diploid pattern (DI = 1.00), the coefficient 
      of variation (CV) is 6.2.
Table 2. Detail of clinicopathologoc parameters, DNA 
         cantents, and numerical chromosome aberra-
        tions in 15 cases of esophageal squamous 
         cell carcinomas.
           size (copy number) 
   Pt. site (mm) grade stage DI 8 11 12 17 X Y 
1. 50M Im 30 poor mpnoMoPIo, I 1.00 3 3 3 1 2 2 
2. 66M Im 45 mode mpnoMoPlo, I 1.64 4 3 3 3 2 0 
 3. 77M lu 40 mode mpnoMoPlo, I 1.66 3 - - 3 - -
4. 78F Iu 29 mode mpnoMoPlo, II 1.83 1 2 2 2 3 -
5. 63M Iu 27 mode mpnoMoPlo, II 1.92 2 1 2 1 2 1 
6. 71M Ei 35 mode mpn,MoPI0, II 1.60 2 2 2 1 2 1 
7. 76M Iu 42 mode a, no MoPIo, II 1.63 4 1 3 1 2 0 
8. 71M Ei 71 mode a2 no MoPIo,I1I 1.64 4 2 2 3 2 -
9. 43M Ei 60 poor a2 no MoPIo, M 1.00 2 2 2 1 2 1 
10. 64M Im 43 mode a2 no MoPIo, III 1.66 3 3 3 3 2 0 
11. 56M Im 45 mode a2 n2 MoPIo, 111 1.47 2 4 3 3 2 0 
12. 51F Im 115 well a2 n2 MoPIo, III 1.00 1 - - 2 - -
13. 73M Ce 80 poor a3 n2 MOPI0,IV 1.67 2 1 3 3 2 0 
14. 65M Im 65 poor a 2 n 3 MoPIo, IV 1.48 2 3 - 2 2 0 
15. 59M Im 65 mode a2 n4 MoPIo, IV 1.38 3 3 1 2 1 2 
M: male, F: female, Ce: cervical esophagus, Iu: upper intra-
thoracic esophagus, Im: middle intra-thoracic esophagus, 
Ei: lower intrathoracic esophagus, well: well diferentiated, 
mode: moderately diferentiated, mp: muscularis propria, a, 
: invasion reaching the adventitia, a2 : definite invasion, a3 : 
invasion into the neighboring structures, no: no lymph node 
metastasis, n,: metastasis to group 1, n2: metastasis to group 
2, n3: metastasis to group 3, n4: metastasis to group 4, Mo: no 
distant metastasis, PI,: no pleural dissemination, DI: DNA 
index
Fig. 2 Flow cytometric DNA histogram of case 13 shows 
      DNA aneuplid pattern (DI = 1.67), the CV is 4.1.
not show a significant correlation with the other 
clinicopathologic parameters such as depth of microscopic 
invasion, distant metastasis, and histological stage. 
 There were nine cases with abnormal copy number of 
chromosome 11, three cases of monosomy, five of trisomy, 
and one of tetrasomy. As for chromosome 12, there were 
six cases with abnormal copy number, one was monosomy 
and remaining five were trisomy. No relationship were 
found between chromosome 11 and 12 copy number and 
clinicopathologic parameters.
Fig. 3 Fluorescence microscopic findings of FISH with 
       chromosome 17 specific DNA probe in case 15, 81
       of the interphase nuclei exhibit two signals.
Table 3. Correlation with copy number of chromosome 8 
         and extension of esophageal squamous cell carci-
        noma.
Fig. 4 Fluorescence microscopic findings of FISH with 
       chromosome 11 specific DNA probe in case 11, 29 % 
       of the interphase nuclei show four signals, indicated 
        as a tetrasomy.
Table 5. Correlation with copy number of chromosome 17 
         and extension of esophageal squamous cell carci-
        noma.
                    No. (%) of patients No. (%) of patients 
Parameteres with monosomy 8 with gain of # 8 
Depth of invasion 
 mp 1/6 (17%) 3/6 (50% ) 
 z a, 1/9 (11%) 4/9 (44% ) 
Lymph node status 
 negative 0/7 ( 0% ) 6/7 (86%) X 
 positive 2/8 (25% ) 1/8 (13%) 
Histological stage 
 stage I / Il 1/7 (14%) 4/7 (57% ) 
 staged /N 1/8 (13%) 3/8 (38% ) 
                                             X p = 0.0089
                    No. (%) of patients No. (%) of patients 
Parameteres with monosomy 17 with gain of # 17 
Depth of invasion 
 mp 3/6 (50%) 2/6 (33% ) 
 zap 2/9(22%) 4/9(44%) 
Lymph node status 
 negative 3/7 (43%) 4/7 (57% ) 
 positive 2/8 (25%) 2/8 (25% ) 
Histological stage 
 stage I / Il 4/7 (57%) X 2/7 (29% ) 
 staged /IV 1/8 (13%) 4/8 (50% ) 
                        X p = 0.1002
Table 4. Correlation with gain of # 8 and lymph node status 
          in mp-cases.
Table 6. Correlation with copy number of chromosome Y 
         and extension of esophageal squamous cell carci-
        noma.
Lymph node status No. (%) of patients 
 negative 3/3 (100%) X 
 positive 0/3 ( 0%I 
                                     X p = 0.05
                   No. (%) of patients No. (%) of patients 
Parameteres with monosomy # Y with gain of # Y 
Depth of invasion 
 mp 1/4 (25%) 1/4 (25% ) 
 z a, 5/7 (71% )~X 1/7 (14% ) 
Lymph node status 
 negative 3/5 (60%) 1/5 (20% ) 
 positive 3/6 (50%) 1/6 (17% ) 
Histological stage 
 stage I / II 2/5 (40%) 1/5 (20% ) 
 stagell /IV 4/6 (67%) 1/6 (17% ) 
                        X p = 0.1970
 Numerical aberrations ofchromosome 17 were found in 
eleven cases (73 %), monosomy in five and trisomy in six. 
Monosomy 17 was seen in four cases (57 %) of stage I 
and II disease, but only in one case (13 %) of stage III and 
IV. Four cases (50 %) of eight stage III /IV disease showed 
trisomy 17, but the difference was not statistically signifi-
cant. There were no correlation with number of chromo-
some 17 and the other clinicopathologic parameters such as 
grade, lymph node status, and depth of microscopic 
invasion. 
 Gain of chromosome X was seen in all cases except for 
one case. Two signals were countable in male cases and 
thrss signals were encountered in female cases. 
 Loss of chromosome Y was seen in six cases (55 %) and 
disomy Y in two cases (18 %). In four cases without 
invasion to the adventitia (a,), only one case (25 %) 
revealed loss of Y. By coutrast, loss of Y was shown in five 
of seven cases (71%) which had invasion to the adventitia, 
but the difference was not statistically significant. The 
number of chromosome Y did not show a significant 
correlation with the other clinicopathologic parameters. 
Comparison with interphase cytogenetics and DNA con-
tent: 
 The DNA indices ranged from 1.00-1.92. The frequency of 
DNA aneuploidy was 80 % of the thirteen cases, and only 
three cases (20 %) revealed DNA diploidy. Two of three 
DNA diploid tumors had no lymph node metastases. Three 
cases with DNA aneuploidy by flow cytometry did not 
accompany any extra copy number in a set of six chromo-
somes except for X chromosome. In all these three pa-
tients, several positive lymph nodes were involved.
DISCUSSION 
 Cytogenetic studies using karyotyping on the basis of 
chromosome banding techniques have shown several 
charasteristic abnormalities in human neoplasms, but it is 
still uncertain whether the chromosomal aberration in 
solid tumors is correlated as closely with clinicopathologic 
features as it is in hematologic malignancies. The interpre-
tation of the chromosome banding patterns is often 
difficult due to the small number of recognizable meta-
phases, minimal chromosome spreading, poor banding 
quality, and condensed or fuzzy appearance of the chromo-
somes"). Technological advances in the field of molecular 
cytogenetics have made it possible to detect chromosomal 
aberrations in interphase cells by using specific DNA 
probes for different centromeric regions together with 
fluorescence in situ hybridization')-"). Therefore, culturing 
of tumor cells is not required and there is no risk of 
selection of a certain highly proliferative subpopulation of 
tumor cells. Its applicantion for interphase cytogenetic 
analysis has increased in recent years because of those
advantages. 
 There are a few reports of FISH applied to gastrointesti-
nal malignancies. In gastric cancer, Dekken et al. 18) showed 
a good correlation between FISH results and the acridine 
orange DNA histograms, and reported that six of eight 
male patients revealed loss of Y chromosome. They 
suggested that loss of Y may be a tumor specific abnor-
mality. Yamaguchi 17) reported that gastric cancers with a 
gain in chromosome 7 and/or 17 were often accompanied 
with a high level of metastasis in lymph nodes and/or 
distant metastasis. In colorectal cancers, numerical 
chromosome aberrations were also found in DNA diploid 
tumors 18) and monosomy 11 was frequent in early stage"). 
On the other hand, in 23 cases of Astler-Coller stage C 
colon cancers, a good correlation was indicated between 
chromosome copy number and tumor proliferative activity 
(S-phase fraction) and DNA ploidy20). Previous study on 
proliferative cell nuclear antigen (: PCNA) expressions 
and numerical chromosome aberrations had also demon-
strated that colorectal carcinomas with high PCNA 
labeling index showed a tendensy of trisomy 1721). 
 In this study, monosomy 17 was frequently found in 
stage I /II esophageal cancer, and trisomy 17 in stage III/ 
IV. The cells with trisomy 17 fail to derive from 
monosomy 17 cell even if mitotic nondisjunction or 
endoreduplication occurs to monosomy 17 cells. Therefore, 
it was taken into consideration that trisomy 17 cells were 
minor subpopulation in early disease, However, these 
showed a potent proliferative activity than the other 
subpopulations, escaping from cell death. This explanation 
contradicts my estimate that subpopulation with 
monosomy 17 is predominant in late stage due to allelic 
loss of p 53/nm 23 tumor/metastasis suppressor gene on 
chromosome 17. Interestingly, the same findings were also 
seen in gastric cancer and colorectal cancer. One possible 
interpretation is that expra copies of chromosome 17 may 
result in a significantly selective growth advantage due to 
high expression of the c-erbB-2 gene coded on the long arm 
of chromosome 17 (17q). 
 Trisomy 8 is a common numerical aberration found in 
hematological disorders"', Ewing's sarcoma"), myxoid lipo-
sarcoma24), pleomorphic adenoma of the parotid gland"), 
uveal melanoma2G)21) , benign nevi'), colon adenoma'), 
breast cancer'), and benign mature teratoma31). A number 
of oncogenes have been mapped to 8 q, including mos and 
c-myc. In chronic and acute myeloid leukemias, it is well 
known that a trisomy 8 is indicative of poor prognosis. 
Furthermore, it was reported that loss of chromosome 3 
alleles and multiplication of 8 q alleles may define a 
subgroup of uveal melanoma with poor prognosis 32). In this 
study, however, six of seven cases (86 %) with gain of 
chromosome 8 had no lymph node metastases. By contrast, 
seven of eight cases (88 %) without gain of chromosome 8 
had positive lymph node involvement. There was a good 
correlation between copy number of chromosome 8 and
lymph node status in patients with esophageal cancer (p = 
0.0089). Of six cases who did not involve the adventitia 
(mp), three cases with gain of chromosome 8 had no nodal 
involvement and three cases without gain had several 
lymph node metastases. This suggests that FISH using 
chromosome 8 specific DNA probe may be helpful to 
determine the method of surgical procedures to the pa-
tients with esophageal cancer. 
  Since esophageal squamous cell carcinomas showed a 
striking male predominance , sex chromosomes were also 
examined in this study. Loss of Y chromosome has been 
reported in various malignancies such as prostatic 
cancer 33> , gastric adenocarcinoma '> , menigioma 35> , renal 
cell carcinoma" and leukemia 37). In this series, loss of Y 
was found in six cases (55 %) of esophageal cancer. In four 
cases without invasion to the adventitia (as) , only one 
case (25 %) revealed loss of Y. By contrast, loss of Y was 
shown in five of seven cases (71 %) who involved the 
adventitia. Although loss of Y has been shown in 
nonneoplastic tissues, including brain), bone marrow'), 
and kidney"), it is assumed that there would exist an 
unidentified gene which suppress invasiveness to the 
adventitia of esophageal cancer on chromosome Y. 
 Combination analysis with DNA content and numerical 
chromosome aberration revealed that all three cases with 
DNA aneuploidy which did not show any extra copy 
number of a set of six chromosomes except for chromo-
some X had several positive lymph nodes. One possible 
explanation is that if more probes were used in these cases, 
the frequency of numerical aberrations would increase 
rather than that in our results. Alternatively, double 
minutes or homogenous staining lesion which may be 
associated with proliferation and progression")") would be 
increased in those cases. Because these fragments have no 
centromeric resions that it is impossible to detect it by 
FISH using centromeric DNA probes. 
  Because of diagnostic progression, it has become possi-
ble to detect the early stage of esophageal cancers which 
are applicable for not only trans-hiatal esophagectomy but 
also endoscopic mucosectomy. If determination of accu-
rate staging, detection of the depth of invasion and the 
presence of lymph node involvement are preoperatively 
feasible, an indication of minimal surgical access would be 
increased. Although endoscopic ultrasonography is an 
important tool, micrometastases to lymph nodes are 
difficult to distinguish from inflammatory changes. 
 In conclusion, the results of this study suggests that 
FISH using endoscopic biopsy specimens is available for 
the judgement of minimal surgical approach. Further 
prospective study is necessary to confirm these findings as 
well as the possible adjunctive prognostic value of chromo-
some copy number in esophageal squamous cell carcinoma.
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